Nothing Special   »   [go: up one dir, main page]

CA2243824A1 - Therapeutic agent for keratoconjunctiva diseases - Google Patents

Therapeutic agent for keratoconjunctiva diseases

Info

Publication number
CA2243824A1
CA2243824A1 CA002243824A CA2243824A CA2243824A1 CA 2243824 A1 CA2243824 A1 CA 2243824A1 CA 002243824 A CA002243824 A CA 002243824A CA 2243824 A CA2243824 A CA 2243824A CA 2243824 A1 CA2243824 A1 CA 2243824A1
Authority
CA
Canada
Prior art keywords
keratoconjunctiva
therapeutic agent
diseases
gefarnate
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002243824A
Other languages
French (fr)
Other versions
CA2243824C (en
Inventor
Katsuhiko Nakata
Masatsugu Nakamura
Takashi Hamano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP08008243A external-priority patent/JP3136352B2/en
Application filed by Individual filed Critical Individual
Publication of CA2243824A1 publication Critical patent/CA2243824A1/en
Application granted granted Critical
Publication of CA2243824C publication Critical patent/CA2243824C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention provides a novel substance which promotes the production and secretion of mucin in ophthalmic tissues.
The therapeutic agent for keratoconjunctiva diseases according to the present invention contains gefarnate as an active ingredient. This therapeutic agent for keratoconjunctiva diseases is applicable to dry eye, keratitis, conjunctivitis, corneal erosion, corneal ulcer, etc. The dosage form is preferably an ophthalmic solution.
Concentration of gefarnate is, for example, 0.1-3% (w/v).
CA002243824A 1996-01-22 1997-01-17 Therapeutic agent for keratoconjunctiva diseases Expired - Fee Related CA2243824C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP08008243A JP3136352B2 (en) 1996-01-22 1996-01-22 Keratoconjunctival disease therapeutic agent
JP8/8243 1996-01-22
PCT/JP1997/000081 WO1997026872A1 (en) 1996-01-22 1997-01-17 Remedy for keratoconjunctival diseases

Publications (2)

Publication Number Publication Date
CA2243824A1 true CA2243824A1 (en) 1997-07-31
CA2243824C CA2243824C (en) 2006-01-03

Family

ID=29422254

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002243824A Expired - Fee Related CA2243824C (en) 1996-01-22 1997-01-17 Therapeutic agent for keratoconjunctiva diseases

Country Status (1)

Country Link
CA (1) CA2243824C (en)

Also Published As

Publication number Publication date
CA2243824C (en) 2006-01-03

Similar Documents

Publication Publication Date Title
CA2225398A1 (en) Pharmaceutical composition comprising albumin as an active ingredient
CA2396561A1 (en) Substituted oxazolidinones and their use in the field of blood coagulation
AU7797887A (en) Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
IE790756L (en) Cerebral therapeutic agent
FI963424A0 (en) Process for the preparation of therapeutically active thiophenesulfonamides
ATE200733T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING FLUOXETINE
EG20001A (en) Process for preparing of novel hydrox-amic acid and N-hydroxyurea derivatives and their use
GR880100578A (en) Ophthalmological cyclosporine composition and preparation method
CA2129287A1 (en) Use of cloprostenol, fluprostenol and their analogues to treat glaucoma and ocular hypertension
MX9702349A (en) Use of 9-deoxy prostaglandin derivatives to treat glaucoma.
CA2289717A1 (en) Novel therapy for constipation
CA2190303A1 (en) Pharmaceutical composition, method and device for preventing or treating dry eye or disease caused therefrom
KR100260061B1 (en) Vitamin e drop
CA2005987A1 (en) Therapeutically active substituted benzimidazole and process for its preparation
CA2340734A1 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
HUT55598A (en) Fungicidal composition comprising new amino acid amide derivatives as active ingredient and process for producing the active ingredients
CA2183486A1 (en) Prostaglandin derivatives
CA2243824A1 (en) Therapeutic agent for keratoconjunctiva diseases
GB2008403A (en) Peptide Compositions
WO1995034302A3 (en) Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators
NO980058L (en) Ophthalmic preparations
IE870577L (en) Topical amide preparation
EP0876817A4 (en) Remedy for keratoconjunctival diseases
MY101266A (en) Pharmaceutical formulations
WO2001028578A3 (en) A PHARMACEUTICAL COMPOSITION CONTAINING pGLU-GLU-PRO-NH2 AND METHOD FOR TREATING DISEASES AND INJURIES TO THE BRAIN, SPINAL CORD AND RETINA USING SAME

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed